{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:21:10Z","timestamp":1776475270903,"version":"3.51.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1 AI126623"],"award-info":[{"award-number":["UM1 AI126623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30 AI 027757-28"],"award-info":[{"award-number":["P30 AI 027757-28"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12915-018-0544-1","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T05:53:37Z","timestamp":1531288417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Viral diversity is an obligate consideration in CRISPR\/Cas9 designs for targeting the HIV reservoir"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4567-8232","authenticated-orcid":false,"given":"Pavitra","family":"Roychoudhury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshana","family":"De Silva Feelixge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan T.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,11]]},"reference":[{"key":"544_CR1","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1165706","volume":"323","author":"DD Richman","year":"2009","unstructured":"Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science (80- ). 2009;323:1304\u20137. \n                    https:\/\/doi.org\/10.1126\/science.1165706\n                    \n                  .","journal-title":"Science (80- )."},{"key":"544_CR2","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009;15:893\u2013900. \n                    https:\/\/doi.org\/10.1038\/nm.1972\n                    \n                  .","journal-title":"Nat Med"},{"key":"544_CR3","doi-asserted-by":"publisher","unstructured":"Soriano-Sarabia N, Archin NM, Bateson R, Dahl NP, Crooks AM, Kuruc JAD, et al. Peripheral V\u03b39V\u03b42 T cells are a novel reservoir of latent HIV infection. PLoS Pathog. 2015;11 \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1005201\n                    \n                  .","DOI":"10.1371\/journal.ppat.1005201"},{"key":"544_CR4","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1126\/science.1141453","volume":"316","author":"I Sarkar","year":"2007","unstructured":"Sarkar I, Hauber I, Hauber J, Buchholz F. HIV-1 proviral DNA excision using an evolved recombinase. Science (80- ). 2007;316:1912\u20135. \n                    https:\/\/doi.org\/10.1126\/science.1141453\n                    \n                  .","journal-title":"Science (80- )"},{"key":"544_CR5","doi-asserted-by":"publisher","unstructured":"Mariyanna L, Priyadarshini P, Hofmann-Sieber H, Krepstakies M, Walz N, Grundhoff A, et al. Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase. PLoS One. 2012;7 \n                    https:\/\/doi.org\/10.1371\/journal.pone.0031576\n                    \n                  .","DOI":"10.1371\/journal.pone.0031576"},{"key":"544_CR6","doi-asserted-by":"publisher","first-page":"7771","DOI":"10.1093\/nar\/gkt571","volume":"41","author":"X Qu","year":"2013","unstructured":"Qu X, Wang P, Ding D, Li L, Wang H, Ma L, et al. Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells. Nucleic Acids Res. 2013;41:7771\u201382. \n                    https:\/\/doi.org\/10.1093\/nar\/gkt571\n                    \n                  .","journal-title":"Nucleic Acids Res"},{"key":"544_CR7","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1038\/srep02510","volume":"3","author":"H Ebina","year":"2013","unstructured":"Ebina H, Misawa N, Kanemura Y, Koyanagi Y. Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep. 2013;3:2510. \n                    https:\/\/doi.org\/10.1038\/srep02510\n                    \n                  .","journal-title":"Sci Rep"},{"key":"544_CR8","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1073\/pnas.1405186111","volume":"111","author":"W Hu","year":"2014","unstructured":"Hu W, Kaminski R, Yang F, Zhang Y, Cosentino L, Li F, et al. RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection. Proc Natl Acad Sci U S A. 2014;111:11461\u20136. \n                    https:\/\/doi.org\/10.1073\/pnas.1405186111\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"544_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","volume":"12","author":"W Zhu","year":"2015","unstructured":"Zhu W, Lei R, Le Duff Y, Li J, Guo F, Wainberg MA, et al. The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA. Retrovirology. 2015;12:22. \n                    https:\/\/doi.org\/10.1186\/s12977-015-0150-z\n                    \n                  .","journal-title":"Retrovirology"},{"key":"544_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.celrep.2016.03.042","volume":"15","author":"Z Wang","year":"2016","unstructured":"Wang Z, Pan Q, Gendron P, Zhu W, Guo F, Cen S, et al. CRISPR\/Cas9-derived mutations both inhibit HIV-1 replication and accelerate viral escape. Cell Rep. 2016;15:481\u20139. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2016.03.042\n                    \n                  .","journal-title":"Cell Rep"},{"key":"544_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.antiviral.2015.12.007","volume":"126","author":"HS De Silva Feelixge","year":"2016","unstructured":"De Silva Feelixge HS, Stone D, Pietz HL, Roychoudhury P, Greninger AL, Schiffer JT, et al. Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy. Antivir Res. 2016;126:90\u20138. \n                    https:\/\/doi.org\/10.1016\/j.antiviral.2015.12.007\n                    \n                  .","journal-title":"Antivir Res"},{"key":"544_CR12","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1016\/j.celrep.2016.11.057","volume":"17","author":"G Wang","year":"2016","unstructured":"Wang G, Zhao N, Berkhout B, Das AT. A combinatorial CRISPR-Cas9 attack on HIV-1 DNA extinguishes all infectious provirus in infected T cell cultures. Cell Rep ElsevierCompany. 2016;17:2819\u201326. \n                    https:\/\/doi.org\/10.1016\/j.celrep.2016.11.057\n                    \n                  .","journal-title":"Cell Rep ElsevierCompany"},{"key":"544_CR13","doi-asserted-by":"publisher","first-page":"E4987","DOI":"10.1073\/pnas.1308313110","volume":"110","author":"L Josefsson","year":"2013","unstructured":"Josefsson L, von Stockenstrom S, Faria NR, Sinclair E, Bacchetti P, Killian M, et al. The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time. Proc Natl Acad Sci. 2013;110:E4987\u201396. \n                    https:\/\/doi.org\/10.1073\/pnas.1308313110\n                    \n                  .","journal-title":"Proc Natl Acad Sci"},{"key":"544_CR14","doi-asserted-by":"publisher","unstructured":"Dampier W, Nonnemacher MR, Mell J, Earl J, Ehrlich GD, Pirrone V, et al. HIV-1 genetic variation resulting in the development of new quasispecies continues to be encountered in the peripheral blood of well-suppressed patients. PLoS One. 2016;11 \n                    https:\/\/doi.org\/10.1371\/journal.pone.0155382\n                    \n                  .","DOI":"10.1371\/journal.pone.0155382"},{"key":"544_CR15","doi-asserted-by":"publisher","first-page":"13475","DOI":"10.1073\/pnas.1406663111","volume":"111","author":"AL Hill","year":"2014","unstructured":"Hill AL, Rosenbloom DI, Fu F, Nowak MA, Siliciano RF. Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1. Proc Natl Acad Sci U S A. 2014;111:13475\u201380. \n                    https:\/\/doi.org\/10.1073\/pnas.1406663111\n                    \n                  .","journal-title":"Proc Natl Acad Sci U S A"},{"key":"544_CR16","doi-asserted-by":"publisher","first-page":"e1005000","DOI":"10.1371\/journal.ppat.1005000","volume":"11","author":"M Pinkevych","year":"2015","unstructured":"Pinkevych M, Cromer D, Tolstrup M, Grimm AJ, Cooper DA, Lewin SR, et al. HIV reactivation from latency after treatment interruption occurs on average every 5-8 days\u2014implications for HIV remission. PLoS Pathog. 2015;11:e1005000. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1005000\n                    \n                  .","journal-title":"PLoS Pathog"},{"key":"544_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol. 2016;34:184\u201391. \n                    https:\/\/doi.org\/10.1038\/nbt.3437\n                    \n                  . Nature Publishing Group","journal-title":"Nat Biotechnol"},{"key":"544_CR18","doi-asserted-by":"publisher","first-page":"e100448","DOI":"10.1371\/journal.pone.0100448","volume":"9","author":"S Xie","year":"2014","unstructured":"Xie S, Shen B, Zhang C, Huang X, Zhang Y. sgRNAcas9: a software package for designing CRISPR sgRNA and evaluating potential off-target cleavage sites. PLoS One. 2014;9:e100448. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0100448\n                    \n                  . Khodursky AB, editor","journal-title":"PLoS One"},{"key":"544_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11515-015-1366-y","volume":"10","author":"LJ Zhu","year":"2015","unstructured":"Zhu LJ. Overview of guide RNA design tools for CRISPR-Cas9 genome editing technology. Front Biol (Beijing). 2015;10:289\u201396. \n                    https:\/\/doi.org\/10.1007\/s11515-015-1366-y\n                    \n                  .","journal-title":"Front Biol (Beijing)"},{"key":"544_CR20","doi-asserted-by":"publisher","unstructured":"Kaminski R, Bella R, Yin C, Otte J, Ferrante P, Gendelman HE, et al. Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study. Gene Ther. 2016:1\u20136. \n                    https:\/\/doi.org\/10.1038\/gt.2016.41\n                    \n                  .","DOI":"10.1038\/gt.2016.41"},{"key":"544_CR21","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/QAD.0000000000001079","volume":"30","author":"C Yin","year":"2016","unstructured":"Yin C, Zhang T, Li F, Yang F, Putatunda R, Young W-B, et al. Functional screening of guide RNAs targeting the regulatory and structural HIV-1 viral genome for a cure of AIDS. AIDS. 2016;30:1163\u201374. \n                    https:\/\/doi.org\/10.1097\/QAD.0000000000001079\n                    \n                  .","journal-title":"AIDS"},{"key":"544_CR22","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12977-015-0148-6","volume":"12","author":"G Li","year":"2015","unstructured":"Li G, Piampongsant S, Faria NR, Voet A, Pineda-Pe\u00f1a A-C, Khouri R, et al. An integrated map of HIV genome-wide variation from a population perspective. Retrovirology. 2015;12:18. \n                    https:\/\/doi.org\/10.1186\/s12977-015-0148-6\n                    \n                  .","journal-title":"Retrovirology"},{"key":"544_CR23","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nbt.3026","volume":"32","author":"JG Doench","year":"2014","unstructured":"Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, et al. Rational design of highly active sgRNAs for CRISPR-Cas9\u2013mediated gene inactivation. Nat Biotechnol. 2014;32:1262\u20137. \n                    https:\/\/doi.org\/10.1038\/nbt.3026\n                    \n                  . Nature Publishing Group","journal-title":"Nat Biotechnol"},{"key":"544_CR24","doi-asserted-by":"publisher","first-page":"e0152499","DOI":"10.1371\/journal.pone.0152499","volume":"11","author":"R Pess\u00f4a","year":"2016","unstructured":"Pess\u00f4a R, Loureiro P, Esther Lopes M, Carneiro-Proietti ABF, Sabino EC, Busch MP, et al. Ultra-deep sequencing of HIV-1 near full-length and partial proviral genomes reveals high genetic diversity among Brazilian blood donors. PLoS One. 2016;11:e0152499. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0152499\n                    \n                  . Kaderali L, editor","journal-title":"PLoS One"},{"key":"544_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med. 2003;9:727\u20138. \n                    https:\/\/doi.org\/10.1038\/nm880\n                    \n                  .","journal-title":"Nat Med"},{"key":"544_CR26","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1093\/infdis\/jiv218","volume":"212","author":"AM Crooks","year":"2015","unstructured":"Crooks AM, Bateson R, Cope AB, Dahl NP, Griggs MK, Kuruc JAD, et al. Precise quantitation of the latent HIV-1 reservoir: implications for eradication strategies. J Infect Dis. 2015;212:1361\u20135. \n                    https:\/\/doi.org\/10.1093\/infdis\/jiv218\n                    \n                  .","journal-title":"J Infect Dis"},{"key":"544_CR27","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41598-017-04160-3","volume":"7","author":"DB Reeves","year":"2017","unstructured":"Reeves DB, Duke ER, Hughes SM, Prlic M, Hladik F, Schiffer JT. Anti-proliferative therapy for HIV cure: a compound interest approach. Sci Rep. 2017;7:4011. \n                    https:\/\/doi.org\/10.1038\/s41598-017-04160-3\n                    \n                  .","journal-title":"Sci Rep"},{"key":"544_CR28","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/COH.0000000000000284","volume":"11","author":"C Spragg","year":"2016","unstructured":"Spragg C, De Silva Feelixge H, Jerome KR. Cell and gene therapy strategies to eradicate HIV reservoirs. Curr Opin HIV AIDS. 2016;11:442\u20139. \n                    https:\/\/doi.org\/10.1097\/COH.0000000000000284\n                    \n                  .","journal-title":"Curr Opin HIV AIDS"},{"key":"544_CR29","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/mt.2016.24","volume":"24","author":"G Wang","year":"2016","unstructured":"Wang G, Zhao N, Berkhout B, Das AT. CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape. Mol Ther. 2016;24:522\u20136. \n                    https:\/\/doi.org\/10.1038\/mt.2016.24\n                    \n                  .","journal-title":"Mol Ther"},{"key":"544_CR30","doi-asserted-by":"publisher","unstructured":"Kaminski R, Chen Y, Fischer T, Tedaldi E, Napoli A, Zhang Y, et al. Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR\/Cas9 gene editing. Sci Rep. 2016; \n                    https:\/\/doi.org\/10.1038\/srep22555\n                    \n                  .","DOI":"10.1038\/srep22555"},{"key":"544_CR31","doi-asserted-by":"publisher","first-page":"e1005740","DOI":"10.1371\/journal.ppat.1005740","volume":"12","author":"M Pinkevych","year":"2016","unstructured":"Pinkevych M, Kent SJ, Tolstrup M, Lewin SR, Cooper DA, S\u00f8gaard OS, et al. Modeling of experimental data supports HIV reactivation from latency after treatment interruption on average once every 5\u20138 days. PLOS Pathog. 2016;12:e1005740. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1005740\n                    \n                  . Swanstrom R, editor","journal-title":"PLOS Pathog."},{"key":"544_CR32","doi-asserted-by":"publisher","first-page":"e1005679","DOI":"10.1371\/journal.ppat.1005679","volume":"12","author":"AL Hill","year":"2016","unstructured":"Hill AL, Rosenbloom DIS, Siliciano JD, Siliciano RF. Insufficient evidence for rare activation of latent HIV in the absence of reservoir-reducing interventions. PLOS Pathog. 2016;12:e1005679. \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1005679\n                    \n                  . Swanstrom R, editor","journal-title":"PLOS Pathog"},{"key":"544_CR33","doi-asserted-by":"publisher","unstructured":"Hernandez-Vargas EA. Modeling kick-kill strategies toward HIV cure. Front Immunol. 2017; \n                    https:\/\/doi.org\/10.3389\/fimmu.2017.00995\n                    \n                  .","DOI":"10.3389\/fimmu.2017.00995"},{"key":"544_CR34","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/apc.2016.0232","volume":"30","author":"KR Jerome","year":"2016","unstructured":"Jerome KR. Disruption or excision of provirus as an approach to HIV cure. AIDS Patient Care STDs. 2016;30:551\u20135. \n                    https:\/\/doi.org\/10.1089\/apc.2016.0232\n                    \n                  .","journal-title":"AIDS Patient Care STDs"},{"key":"544_CR35","doi-asserted-by":"publisher","first-page":"8920","DOI":"10.1128\/JVI.00052-12","volume":"86","author":"JT Schiffer","year":"2012","unstructured":"Schiffer JT, Aubert M, Weber ND, Mintzer E, Stone D, Jerome KR. Targeted DNA mutagenesis for the cure of chronic viral infections. J Virol. 2012;86:8920\u201336. \n                    https:\/\/doi.org\/10.1128\/JVI.00052-12\n                    \n                  .","journal-title":"J Virol"},{"key":"544_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/COH.0b013e32835f736c","volume":"8","author":"D Stone","year":"2013","unstructured":"Stone D, Kiem HP, Jerome KR. Targeted gene disruption to cure HIV. Curr Opin HIV AIDS. 2013;8:217\u201323. \n                    https:\/\/doi.org\/10.1097\/COH.0b013e32835f736c\n                    \n                  .","journal-title":"Curr Opin HIV AIDS"},{"key":"544_CR37","doi-asserted-by":"publisher","unstructured":"Roychoudhury P, De Silva Feelixge HS, Pietz HL, Stone D, Jerome KR, Schiffer JT. Pharmacodynamics of anti-HIV gene therapy using viral vectors and targeted endonucleases. J Antimicrob Chemother. 2016:dkw104. \n                    https:\/\/doi.org\/10.1093\/jac\/dkw104\n                    \n                  .","DOI":"10.1093\/jac\/dkw104"},{"key":"544_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep41968","volume":"7","author":"RJ Lebbink","year":"2017","unstructured":"Lebbink RJ, De Jong DCM, Wolters F, Kruse EM, Van Ham PM, Wiertz EJHJ, et al. A combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Sci Rep. 2017;7:1\u201310. \n                    https:\/\/doi.org\/10.1038\/srep41968\n                    \n                  . Nature Publishing Group","journal-title":"Sci Rep"},{"key":"544_CR39","doi-asserted-by":"publisher","unstructured":"Brodin J, Zanini F, Thebo L, Lanz C, Bratt G, Neher RA, et al. Establishment and stability of the latent HIV-1 DNA reservoir. elife. 2016;5 \n                    https:\/\/doi.org\/10.7554\/eLife.18889\n                    \n                  .","DOI":"10.7554\/eLife.18889"},{"key":"544_CR40","doi-asserted-by":"publisher","unstructured":"Kearney MF, Spindler J, Shao W, Yu S, Anderson EM, O\u2019Shea A, et al. Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy. PLoS Pathog. 2014;10 \n                    https:\/\/doi.org\/10.1371\/journal.ppat.1004010\n                    \n                  .","DOI":"10.1371\/journal.ppat.1004010"},{"key":"544_CR41","doi-asserted-by":"publisher","unstructured":"Kearney MF, Wiegand A, Shao W, McManus WR, Bale MJ, Luke B, et al. Ongoing HIV replication during ART reconsidered. Open Forum Infect Dis. 2017;4 \n                    https:\/\/doi.org\/10.1093\/ofid\/ofx173\n                    \n                  .","DOI":"10.1093\/ofid\/ofx173"},{"key":"544_CR42","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/nm.2892","volume":"18","author":"DIS Rosenbloom","year":"2012","unstructured":"Rosenbloom DIS, Hill AL, Rabi SA, Siliciano RF, Nowak MA. Antiretroviral dynamics determines HIV evolution and predicts therapy outcome. Nat Med. 2012;18:1378\u201385. \n                    https:\/\/doi.org\/10.1038\/nm.2892\n                    \n                  .","journal-title":"Nat Med"},{"key":"544_CR43","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.1038\/nature24635","volume":"551","author":"R Lorenzo-Redondo","year":"2017","unstructured":"Lorenzo-Redondo R, Fryer HR, Bedford T, Kim EY, Archer J, Pond SLK, et al. Lorenzo-Redondo et al. reply. Nature. 2017;551:E10. \n                    https:\/\/doi.org\/10.1038\/nature24635\n                    \n                  .","journal-title":"Nature"},{"key":"544_CR44","doi-asserted-by":"publisher","unstructured":"Yin L, Hu S, Mei S, Sun H, Xu F, Li J, et al. CRISPR\/Cas9 inhibits multiple steps of HIV-1 infection. Hum Gene Ther. 2018; \n                    https:\/\/doi.org\/10.1089\/hum.2018.018\n                    \n                  .","DOI":"10.1089\/hum.2018.018"},{"key":"544_CR45","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","volume":"25","author":"C Yin","year":"2017","unstructured":"Yin C, Zhang T, Qu X, Zhang Y, Putatunda R, Xiao X, et al. In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models. Mol Ther. 2017;25:1168\u201386. \n                    https:\/\/doi.org\/10.1016\/j.ymthe.2017.03.012\n                    \n                  .","journal-title":"Mol Ther"},{"key":"544_CR46","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse M, Moir R, Wilson A, Stones-Havas S, Cheung M, Sturrock S, et al. Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics. 2012;28:1647\u20139. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/bts199\n                    \n                  .","journal-title":"Bioinformatics"},{"key":"544_CR47","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320. \n                    https:\/\/doi.org\/10.1093\/bioinformatics\/btu170\n                    \n                  .","journal-title":"Bioinformatics"},{"key":"544_CR48","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139. \n                    https:\/\/doi.org\/10.1038\/nmeth.1923\n                    \n                  .","journal-title":"Nat Methods"},{"key":"544_CR49","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1101\/gr.849004","volume":"14","author":"GE Crooks","year":"2004","unstructured":"Crooks GE. WebLogo: a sequence logo generator. Genome Res. 2004;14:1188\u201390. \n                    https:\/\/doi.org\/10.1101\/gr.849004\n                    \n                  .","journal-title":"Genome Res"},{"key":"544_CR50","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/0022-2836(86)90165-8","volume":"188","author":"TD Schneider","year":"1986","unstructured":"Schneider TD, Stormo GD, Gold L, Ehrenfeucht A. Information content of binding sites on nucleotide sequences. J Mol Biol. 1986;188:415\u201331. \n                    https:\/\/doi.org\/10.1016\/0022-2836(86)90165-8\n                    \n                  .","journal-title":"J Mol Biol"},{"key":"544_CR51","doi-asserted-by":"publisher","first-page":"e1003806","DOI":"10.1371\/journal.pcbi.1003806","volume":"10","author":"G Finak","year":"2014","unstructured":"Finak G, Frelinger J, Jiang W, Newell EW, Ramey J, Davis MM, et al. OpenCyto: an open source infrastructure for scalable, robust, reproducible, and automated, end-to-end flow cytometry data analysis. PLoS Comput Biol. 2014;10:e1003806. \n                    https:\/\/doi.org\/10.1371\/journal.pcbi.1003806\n                    \n                  .","journal-title":"PLoS Comput Biol"},{"key":"544_CR52","doi-asserted-by":"publisher","unstructured":"Kuznetsova A, Brockhoff PB, Christensen RHB. lmerTest package: tests in linear mixed effects models. J Stat Softw. 2017;82 \n                    https:\/\/doi.org\/10.18637\/jss.v082.i13\n                    \n                  .","DOI":"10.18637\/jss.v082.i13"},{"key":"544_CR53","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2307\/4615733","volume":"6","author":"SA Holm","year":"1979","unstructured":"Holm SA. Simple sequentially Rejective multiple test procedure. Scand J Stat. 1979;6:65\u201370. \n                    https:\/\/doi.org\/10.2307\/4615733\n                    \n                  .","journal-title":"Scand J Stat"},{"key":"544_CR54","doi-asserted-by":"publisher","unstructured":"Jaafoura S, De Go\u00ebr De Herve MG, Hernandez-Vargas EA, Hendel-Chavez H, Abdoh M, Mateo MC, et al. Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4+memory T cells. Nat Commun 2014;5. \n                    https:\/\/doi.org\/10.1038\/ncomms6407\n                    \n                  .","DOI":"10.1038\/ncomms6407"},{"key":"544_CR55","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1093\/cid\/ciu585","volume":"59","author":"GJ Besson","year":"2014","unstructured":"Besson GJ, Lalama CM, Bosch RJ, Gandhi RT, Bedison MA, Aga E, et al. HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy. Clin Infect Dis. 2014;59:1312\u201321. \n                    https:\/\/doi.org\/10.1093\/cid\/ciu585\n                    \n                  .","journal-title":"Clin Infect Dis"},{"key":"544_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"Y-C Ho","year":"2013","unstructured":"Ho Y-C, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DIS, et al. Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell. 2013;155:540\u201351. \n                    https:\/\/doi.org\/10.1016\/j.cell.2013.09.020\n                    \n                  . Elsevier Inc","journal-title":"Cell"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-018-0544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12915-018-0544-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-018-0544-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T08:51:52Z","timestamp":1589446312000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-018-0544-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,11]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1186\/s12915-018-0544-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/255133","asserted-by":"object"}]},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,11]]},"assertion":[{"value":"26 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"75"}}